Zyversa Therapeutics Inc banner
Z

Zyversa Therapeutics Inc
OTC:ZVSA

Watchlist Manager
Zyversa Therapeutics Inc
OTC:ZVSA
Watchlist
Price: 0.1846 USD -40.7% Market Closed
Market Cap: $850k

Wall St Price Targets

ZVSA Price Targets Summary
Zyversa Therapeutics Inc

There are no price targets for ZVSA.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Zyversa Therapeutics Inc Competitors:
Price Targets
APA
APA Corp (US)
3% Upside
ACAD
ACADIA Pharmaceuticals Inc
13% Upside
VRNS
Varonis Systems Inc
24% Upside
AMP
Amper SA
28% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Zyversa Therapeutics Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-76%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-76%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ZVSA's stock price target?
Not Available

ZVSA does not have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett